JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lichtensteiger, W.
Right arrow Articles by Langemann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lichtensteiger, W.
Right arrow Articles by Langemann, H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 151, Issue 3, 400-408, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


UPTAKE OF EXOGENOUS CATECHOLAMINES BY MONOAMINE-CONTAINING NEURONS OF THE CENTRAL NERVOUS SYSTEM: UPTAKE OF CATECHOLAMINES BY ARCUATO-INFUNDIBULAR NEURONS

Walter Lichtensteiger 1 and Heinrich Langemann 1

1 Department of Pharmacology, University of Zurich, Zurich, Switzerland

The uptake of norepinephrine (NE), epinephrine (E), dopamine (DA) and 3,4-dihydroxyphenylalanine (dopa) into the mouse brain has been studied by means of the histochemical fluorescence method of Falck. Prior to the intraperitoneal administration of one of the catecholamines or of dopa, the amine stores were depleted by reserpine and monoamine oxidase was inhibited by Nialamide. In addition, azapetine was given shortly before high doses of NE or E. The animals were killed 5 hr after reserpine, when no green fluorescence (indicating the presence of a catecholamine) was observed in the controls. The uptake of NE administered in high doses was found to be limited to nerve cell bodies in the nucleus arcuatus, with axons descending to the external layer of the median eminence, nucleus periventricularis anterior and posterior hypothalami, area retrochiasmatica, area postrema and bulbus olfactorius and nerve endings in the median eminence. After smaller doses of NE the fluorescence intensity decreased accordingly. After DA and E, only a weak green fluorescence developed in these neurons even if high doses were given. The existence of a catecholamine-containing arcuatoinfundibular neuron is indicated by the demonstration of green fluorescent axons which connect green fluorescent nerve cell bodies in the arcuate nucleus with their nerve endings in the median eminence. In both regions, green fluorescent nerve cells and nerve endings respectively are also found in normal, untreated animals. The nerve endings are situated in the region of the primary plexus of the hypophyseal portal system.

Accepted on September 24, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.